Universal Health Services' $500M Punitive Damages Verdict Vacated; Judge Grants New Trial
UHS sits 44% above its 52-week low of $152.328.
Summary
A judge vacated a $500 million punitive damages verdict against Universal Health Services, granting a new trial, significantly reducing a major legal liability, while the company also reported strong 2025 financial results and a positive 2026 outlook.
Key Events · Legal and Risk Events · UHS
-
$500 Million Punitive Damages Verdict Vacated
A judge granted a new trial based on juror misconduct, anticipating the vacation of a $500 million punitive damages verdict against a subsidiary in a Nevada lawsuit. This significantly reduces a major potential liability, as the statutory cap for punitive damages in Nevada is approximately $14 million.
-
Strong 2025 Financial Performance
The company reported a 30.4% increase in full-year 2025 net income attributable to UHS to $1.489 billion and a 9.7% rise in net revenues to $17.365 billion, compared to 2024.
-
Positive 2026 Operating Outlook
Management provided a 2026 forecast with midpoint net revenues increasing by 7.1% and adjusted diluted EPS by 8.5% over 2025, indicating continued growth expectations.
-
Significant Share Repurchase Activity
In 2025, the company repurchased 4.65 million shares for approximately $899.3 million, with $1.425 billion remaining under the authorized stock repurchase program as of year-end.
Analysis · UHS · Industrial Applications And Services
This filing contains a highly significant update regarding a previously disclosed lawsuit. A judge has verbally ordered a new trial based on juror misconduct, which is expected to vacate a $500 million punitive damages verdict against a Universal Health Services subsidiary. This development substantially reduces a major potential liability, as even if the verdict were reinstated on appeal, Nevada statutory law would cap punitive damages at approximately $14 million. This de-risking event is a strong positive for the company. Additionally, the filing reiterates strong financial results for 2025, including a 30.4% increase in net income and a 9.7% rise in net revenues, along with a positive operating forecast for 2026. The company also demonstrated confidence through significant share repurchases in 2025.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.8% of the 328 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UHS was trading at $219.15 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $14.4B. The 52-week trading range was $152.33 to $246.33. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.